Home
Hogan Lovells
Susan S. Lee
Susan S. Lee
Hogan Lovells
"Misleading" To Suggest A Biosimilar Is Inferior, FDA Draft Guidance Warns
11 Feb 2020 | United States
2019 OPDP Enforcement Letters Target How Drug Risk Information Is Conveyed In Promotional Materials
30 Jan 2020 | United States
FDA Wants To Hear From You: Proposed Framework For Regulating Output Of Digital Health Tools Accompanying Prescription Drugs As Labeling
29 Nov 2018 | United States
Contact Details
Brussels
Brussels
Belgium

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.